Diagnostic and therapeutic technology assessment. Transrectal ultrasonography in prostatic cancer.
The DATTA panelists believe that transrectal ultrasound is established as safe for the screening and staging of prostatic cancer. The majority did not believe, however, that the effectiveness of the procedure has been established yet for either screening or staging. The panelists and the literature indicate, however, that transrectal ultrasound may well have a significant role to play in the future treatment of prostatic cancers.
D000368:Aged; D000574:American Medical Association; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D012680:Sensitivity and Specificity; D013673:Technology Assessment, Biomedical; D014463:Ultrasonography / Q000191:economics / Q000379:methods*; D014481:United States